Pauline Funchain, Medical Oncologist and Cancer Genomic Medicine Fellow at Cleveland Clinic, shared a post on X:
“Is a cure possible with TIL?
Allison Betof, Stanford Cancer Institute, reviews exceedingly durable responses in those who get CR with TIL as well as 5-year TIL data showing the capacity for responses that deepen over time (circled) – MOASC, ANCO Immuno Oncology Symposium.”
More posts featuring Pauline Funchain.
